AdaptHealth Corp. (AHCO)
$
9.45
+0.07 (0.74%)
Key metrics
Financial statements
Free cash flow per share
1.7139
Market cap
1.3 Billion
Price to sales ratio
0.3945
Debt to equity
1.2285
Current ratio
1.0577
Income quality
6.2142
Average inventory
139.1 Million
ROE
0.0516
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
AdaptHealth Corp., along with its subsidiaries, plays a pivotal role in providing home medical equipment (HME), medical supplies, and a variety of related services across the United States. The company specializes in delivering essential sleep therapy equipment and supplies, including CPAP and bi-PAP services, catering to individuals afflicted with obstructive sleep apnea. It also offers vital medical devices such as continuous glucose monitors and insulin pumps for diabetes management, alongside HME for patients transitioning from acute care facilities. Additionally, AdaptHealth facilitates oxygen and related chronic therapy services at home, and supplies HME devices for individuals with chronic conditions requiring wound care, urological assistance, incontinence solutions, ostomy products, and nutritional support. The net total of other income and expenses is -$127,713,000.00 reflecting non-core financial activities tied to the business. The EBITDA ratio is 0.09 highlighting the company’s operational efficiency in managing its resources. Moreover, the total costs and expenses for the company amount to $2,997,243,000.00 indicating its overall spending habits within the healthcare sector. The weighted average number of shares outstanding is 133,756,000.00 showcasing the scale of the company's shareholder base. Finally, the income before tax ratio is 0.04 which reflects the pre-tax margin and underlying profitability. From an investment perspective, the stock is affordable at $9.17 making it suitable for budget-conscious investors looking for accessible opportunities in the market. With an average trading volume of 1,268,350.00 the stock indicates a moderate level of liquidity, suggesting a reasonable ease of transaction for investors. Furthermore, with a market capitalization of $1,278,566,100.00 the company is classified as a small-cap player within the broader market. AdaptHealth Corp. is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape with its innovative solutions. Additionally, it belongs to the Healthcare sector, driving innovation and growth, which positions it favorably for future opportunities.
Is AdaptHealth Corp. (AHCO) a good investment?
Investing in AdaptHealth Corp. (AHCO) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
What is AdaptHealth Corp. (AHCO)'s stock forecast?
Analysts predict AdaptHealth Corp. stock to fluctuate between $7.11 (low) and $11.70 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is AdaptHealth Corp.'s market capitalization?
As of 2025-08-20, AdaptHealth Corp.'s market cap is $1,278,566,100, based on 135,298,000 outstanding shares.
How does AdaptHealth Corp. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, AdaptHealth Corp. has a Lower Market-Cap, indicating a difference in performance.
How can I buy AdaptHealth Corp. (AHCO) stock?
To buy AdaptHealth Corp. (AHCO) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AHCO. Place an order (Market, Limit, etc.).
What is the best time to invest in AdaptHealth Corp.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did AdaptHealth Corp. perform in the last earnings report?
Revenue: $3,260,975,000 | EPS: $0.62 | Growth: -111.65%.
Where can I find AdaptHealth Corp.'s investor relations reports?
Visit https://adapthealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for AdaptHealth Corp.?
You can explore historical data from here
What is the all-time high and low for AdaptHealth Corp. stock?
All-time high: $28.75 (2021-11-04) | All-time low: $6.37 (2023-11-08).
What are the key trends affecting AdaptHealth Corp. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Investors need to pay close attention to AHCO stock based on the movements in the options market lately.
seekingalpha.com
AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers.
seekingalpha.com
AdaptHealth Corp. (NASDAQ:AHCO ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Suzanne Foster - CEO Jason Clemens - CFO Conference Call Participants Meghan Holtz - Jefferies Pito Chickering - Deutsche Bank Eric Coldwell - Baird Kevin Caliendo - UBS Ben Hendrix - RBC Capital Markets Mathew Blackman - Stifel Whit Mayo - Leerink Partners John Pinney - Canaccord Genuity Operator Good day, everyone, and welcome to today's AdaptHealth First Quarter 2025 Earnings Release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
zacks.com
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
seekingalpha.com
AdaptHealth Corp specializes in sleep therapy equipment and respiratory health. These two focus segments also command the best margins for the company. Q4 2024 results exceeded expectations, driving a 30% stock surge; the company reported a record 12.3% operating income margin.
zacks.com
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
seekingalpha.com
AdaptHealth Corp. (NASDAQ:AHCO ) Q4 2024 Earnings Conference Call February 25, 2025 8:30 AM ET Company Participants Suzanne Foster – Chief Executive Officer Jason Clemens – Chief Financial Officer Conference Call Participants Ben Hendrix – RBC Capital Markets Mathew Blackman – Stifel Brian Tanquilut – Jefferies Richard Close – Canaccord Eric Coldwell – Baird Kieran Ryan – Deutsche Bank Operator Good day, everyone and welcome to today's AdaptHealth Fourth Quarter 2024 Earnings Release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
zacks.com
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.64 per share a year ago.
See all news
